Summary of the main outcome parameters
| Parameters | Reference number | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lung function parameters | 26 | 37 | 3 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 2 | 50 | 51 | 52 |
| PEF | − | + | + | − | + | − | − | + | − | ||||||||||||||||||||
| FEV1 | − | + | − | − | − | − | − | − | − | − | + | + | − | − | − | − | − | − | − | − | |||||||||
| FEF25–75 | − | − | − | − | − | − | − | − | |||||||||||||||||||||
| FVC | − | + | − | − | − | + | − | − | − | − | − | − | |||||||||||||||||
| FEV1/FVC | − | − | − | − | − | − | − | − | − | ||||||||||||||||||||
| VC | − | − | − | − | |||||||||||||||||||||||||
| Cardiorespiratory parameters | |||||||||||||||||||||||||||||
| VO2max | + | − | + | − | − | − | − | + | + | + | |||||||||||||||||||
| Ventilatory threshold | + | ± | + | ||||||||||||||||||||||||||
| VEmax | − | − | − | + | − | + | |||||||||||||||||||||||
| O2pulsemax | + | ± | + | ||||||||||||||||||||||||||
| HRmax | − | + | − | + | − | ± | |||||||||||||||||||||||
| Wmax | + | − | − | + | |||||||||||||||||||||||||
| Working capacity | − | + | − | ||||||||||||||||||||||||||
| Asthma control | |||||||||||||||||||||||||||||
| EIB | − | + | + | − | − | + | − | ||||||||||||||||||||||
| Bronchial hyper responsiveness | − | − | + | ||||||||||||||||||||||||||
| PAQLQ | + | + | − | ||||||||||||||||||||||||||
| Symptom scores | − | + | − | ||||||||||||||||||||||||||
| Asthma attacks | − | + | + | ||||||||||||||||||||||||||
| Days of wheezing | + | + | |||||||||||||||||||||||||||
| Medication scores | − | − | − | ||||||||||||||||||||||||||
+=Significant change in the training group compared with the control group after the training programme (p<0.05).
−=No significant change after training in the training group compared with the control group (p>0.05).
+/−=Significant changes after two different exercise periods (first period: 3 month aerobic training; second period: 3 months high-intensity training).
EIB, exercise-induced bronchoconstriction; FEF, forced expiratory flow; FEV, forced expiratory volume; FVC, forced vital capacity; HRmax, maximal heart rate; PAQLQ, Paediatric asthma quality of life questionnaire; VC, vital capacity; VEmax, maximal minute ventilation; VO2max, maximal oxygen uptake.